14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
BLNE vs ACCL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, ACCL (ACCL) is the stronger overall head-to-head candidate over Beeline Holdings, Inc. (BLNE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). BLNE carries a Unified Composite Score of 43.4/100 (HOLD) at $0.29 (5.5x Forward P/E, -179.8% operating margin), whereas ACCL carries 64.5/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin).
Growth vs. Quality Trade-Off: ACCL earns the overall head-to-head edge with a stronger Unified Composite Score (64.5/100 BUY vs. BLNE 43.4/100 HOLD) and -0.16β · 56% Vol risk profile, whereas BLNE leads top-line expansion (+29.8% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: BLNE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 19.1); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BLNE vs ACCL. Trailing 12-month operating profitability (BLNE -179.8% vs ACCL 4.5%) and valuation multiples (BLNE 5.5x vs ACCL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consulting Services value chain with $33.1M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment37.9% of Rev ($2.0M)
90D Engineering Disclosures0 Published
Investor FAQ BLNE vs ACCL Key Questions & Quantitative Answers
As of Nov 20, 2026, ACCL (ACCL) is the stronger overall head-to-head candidate over Beeline Holdings, Inc. (BLNE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). BLNE carries a Unified Composite Score of 43.4/100 (HOLD) at $0.29 (5.5x Forward P/E, -179.8% operating margin), whereas ACCL carries 64.5/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin). Growth vs. Quality Trade-Off: ACCL earns the overall head-to-head edge with a stronger Unified Composite Score (64.5/100 BUY vs. BLNE 43.4/100 HOLD) and -0.16β · 56% Vol risk profile, whereas BLNE leads top-line expansion (+29.8% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BLNE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 19.1); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BLNE leads the Growth & Scale pillar: BLNE posts +29.8% YoY revenue growth and +0.0% YoY earnings growth on $12M TTM revenue (100.0% gross margin, -179.8% operating margin), compared with ACCL at +11.3% YoY revenue growth and -62.5% YoY earnings growth on $5.2M TTM revenue (42.4% gross margin, 4.5% operating margin). On trailing 12-month operating scale, BLNE generates $12M in USD-normalized revenue versus $5.2M for ACCL. In operating R&D and SG&A reinvestment, BLNE deploys N/A (0 90-day corporate R&D disclosures) versus 37.9% of Rev ($2.0M) (0 disclosures) for ACCL.
BLNE screens cheaper on headline valuation multiples. BLNE trades at 5.5x Forward P/E, 5.5x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (unreported FCF margin), whereas ACCL trades at N/M Forward P/E, 118.5x Trailing P/E, N/M PEG, and 6.4x EV/Revenue (4.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BLNE (-42.4% ROE) versus ACCL (7.0% ROE) capital efficiency.
In options market volatility and institutional positioning, BLNE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.74β · 123% Vol realized risk). By comparison, ACCL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.16β · 56% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.